CLINICAL_TRIALS
trial_result
· 2016-02-17
Clinical Trial Update: Atacicept in Subjects With Optic Neuritis [Phase 2]
Summary
This is a Phase 2 trial update for atacicept in optic neuritis; the study was terminated and results were posted on 2016-02-17.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Optic Neuritis | Phase 2 | Status: TERMINATED | Results posted: 2016-02-17